Table 3.
Author | Year | Subjects (n) | Comparison | CT System | Acquisition parameters | Reconstruction name (level) | Dose reduction (%) | CTDIvol (mGy) |
DLP (mGy * cm) |
E (mSv) |
---|---|---|---|---|---|---|---|---|---|---|
Kaul [36] | 2016 |
177 71SD 86LD1 20LD2 |
SDFBP vs. LD1ASIR20 vs. LD2ASIR30 | 64-MDCT (GE Lightspeed VCT, GE Healthcare, Milwaukee, WI, USA) |
120 kV, 100–300 mAam, SD 120 kV, 100–300 mAam, LD |
FBP HIR (ASIR 20%, 30%) |
41LD1 73LD2 |
51.6SD 30.2LD1 13.9LD2 |
768.0SD 455.0LD1 204.0LD2 |
1.6SD 1.1LD1 0.4LD2 |
Ozdoba [34] | 2014 |
75 50SD 25LD |
SDFBP vs. LDHIR |
16/64-MDCT (Siemens SOMATOM Sensation, Siemens Healthineers, Erlangen, Germany)SD 128-MDCT (Siemens Somatom Definition Edge, Siemens Healthineers, Erlangen, Germany)LD |
120 kV, 220/380 mAsSD 100 kV, 230 mAsLD |
FBP HIR (SAFIRE) |
40 |
57.2SD 34.9LD |
964.0SD 574.1LD |
NA |
Korn [33] | 2013 |
60 30SD 30LD |
SDFBP vs. LDFBP, HIR | 128-MDCT (Siemens Somatom Definition Flash, Siemens Healthineers, Erlangen, Germany) |
120 kV, 320 mAsSD 120 kV, 255 mAsLD |
FBP HIR (SAFIRE 3) |
20 |
59.7SD 47.8LD |
1042.0SD 829.0LD |
2.2SD 1.7LD |
Kilic [28] | 2013 |
305 152SD 153LD |
SDFBP vs. LDASIR | 16-MDCT (GE Lightspeed VCT) |
100/120 kV, 200–420 mASD 100/120 kV, 100–290 mALD |
FBP HIR (ASIR 30%) |
30 |
38.8pf/29.0cer SD 27.7pf/20.2cer LD |
466.5SD 329.2LD |
2.2SD 1.5LD |
Korn [57] | 2012 |
90 30SD 30LD1 30LD2 |
SD vs. LD1 vs. LD2 | 128-MDCT (Siemens SOMATOM Definition Flash, Siemens Healthineers, Erlangen, Germany) |
120 kV, 320 mAsSD 120 kV, 275 mAs LD1 120 kV, 225 mAs LD2 |
FBP IRIS |
15SD-LD1 30SD-LD2 |
60.1SD 51.8LD1 42.3LD2 |
1043.0SD 890.0LD1 733.0LD2 |
2.2SD 1.8LD1 1.5LD2 |
Rapalino [32] | 2012 |
150 50SD 100LD |
SDFBP vs. LDASIR | 64-MDCT (GE Discovery CT750HD, GE Healthcare, Milwaukee, WI, USA) |
120 kV, 250 mA, 175 mAsSD 120 kV, 200 mA, 140 mAsLD |
FBP HIR (ASIR 20–100%) |
26 |
66.5SD 49.7LD |
1270.3SD 932.3LD |
2.7SD 2.0LD |
Becker [31] | 2012 |
150 50SD 50LD1 50LD2 |
SDFBP vs. LD1FBP vs. LD2IRIS | MDCT (Siemens Somatom Definition Flash) |
120 kV, 320 mAsSD 120 kV, 390 mAsam, LD1, LD2 |
FBP IRIS |
24CTDI 20DLP |
60.0SD 46.0LD1 45.0LD2 |
887.0SD 722.0LD1 708.0LD2 |
NA |
Kilic [30] | 2011 |
149 51SD 98LD |
SDFBP vs. LDASIR | 16-MDCT (GE Brightspeed, GE Healthcare, Milwaukee, WI, USA) |
140pf/120cer kV, 170pf/270cer mA SD 140pf/120cer kV, 125pf/190cer mA SD |
FBP HIR (ASIR 30%) |
26pf, CTDI 35cer, CTDI 31DLP |
93.5pf, SD 59.4cer, SD 69.1pf, LD 38.6cer, LD |
1081.3SD 748.6LD |
2.3SD 1.6LD |
am automatic tube current modulation, ASIR adaptive statistical iterative reconstruction, ASIR20/30 adaptive statistical iterative reconstruction at level 20/30/40% (available options: 0–50% in 10% increments), cer cerebrum, CTDI based on CTDIvol, FBP filtered back projection, HIR hybrid iterative reconstruction, IRIS iterative reconstruction in image space, LD low-dose, LD1 low-dose protocol 1, LD2 low-dose protocol 2, pf posterior fossa, SAFIRE sinogram-affirmed iterative reconstruction, SAFIRE1–5 SAFIRE at level 1–5, SD standard-dose, SD-LD1 dose reduction between standard-dose protocol and low-dose protocol 1, SD-LD2 dose reduction between standard-dose protocol dose and low-dose protocol